MedPath

Randomized Controlled Trial of Integrated Early Palliative Care

Not Applicable
Completed
Conditions
Solid Tumor
Advanced Cancer
Interventions
Behavioral: Telephone coaching
Behavioral: Consultation with PCT doctor
Registration Number
NCT03181854
Lead Sponsor
Seoul National University Hospital
Brief Summary

This study verifies whether integrated Early Palliative Care for advanced cancer patients diagnosed due to a solid tumor improve quality of life and enhances the ability to overcome the current crisis.

Detailed Description

Previous reports suggest that starting palliative care early in cancer patients appears to improve patient's quality of life, symptom management, depression, and anxiety.

This study aims to evaluate the effect of the introduction of early palliative care services to advanced cancer patients. Eligible patients are 20 years or older, and has an advanced cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor, a European Cooperative Oncology Group performance status of 0-2, an estimated life expectancy of 12 months or less. The primary goal of an integrated early palliative care program is to improve the overall quality of life of patients and their families. Secondarily, it is to help understand the disease, resolving conflicts in the decision-making process, improving the crisis coping capacity, and further determining the patient's and family's advanced care planning. At last, it is desired to evaluate the effect of the program on overall medical cost savings and 1 year survival.

Participants of the study will be allocated in the intervention group and the control group equally. Within three weeks from the time of randomization, the first meeting with a palliative care team will be held. In the time of baseline questionnaire, patients will be provided with self-study education materials and videos on the early palliative care and advance care planning. Once in every three weeks for six months, which is the duration for one treatment course, palliative care for advance care planning, symptom control, and other mental, social and spiritual problems will be provided. After the first meeting with the palliative care team, telephone coaching will be performed once a week for the first 12 weeks and then every two weeks until the end of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
144
Inclusion Criteria
  • Subject 20 years and older.
  • Subject who has an advanced cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor
  • Subject whose ECOG performance status is between 0 to 2.
  • Subject with an estimated life expectancy of 12 months and less (assessed by the treating oncologist)
  • Subject who volunteers
Exclusion Criteria
  • Inability to speak, understand or write Korean.
  • Medical conditions that would limit adherence to participation of the clinical trial(as confirmed by their referring physician; e.g. dyspnea)
  • Suspension of all cancer treatment
  • Palliative care consultation at any time or in palliative care

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupTelephone coachingConsultation with PCT doctor every 3 weeks. Telephone coaching once a week for 3 months and once in 2 weeks for another 3 months.
Intervention groupConsultation with PCT doctorConsultation with PCT doctor every 3 weeks. Telephone coaching once a week for 3 months and once in 2 weeks for another 3 months.
Primary Outcome Measures
NameTimeMethod
Change in level of EORTC QLQ-C15-PALbaseline, 12 weeks, 18 weeks, 24 weeks

A questionnaire developed to assess the quality of life of palliative cancer care patients.

Secondary Outcome Measures
NameTimeMethod
Change in level of MQOLBaseline, 12 weeks, 18 weeks, 24 weeks

A questionnaire that measures psychological, existential well-being, and support.

Change in level of EQ-5D of EuroQoLBaseline, 12 weeks, 18 weeks, 24 weeks

A questionnaire that measures mobility, self-care, daily activity, pain/discomfort, and anxiety/depression.

Change in level of PHQ-9Baseline, 12 weeks, 18 weeks, 24 weeks

9-question instrument given to patients in a primary care setting to screen for the presence and severity of depression.

Change in level of Understanding the illnessBaseline, 12 weeks, 18 weeks, 24 weeks

2 questions to assess how patients understand the prognosis of their illness

Change in level of Crisis Overcoming Capability(SAT-SF)Baseline, 12 weeks, 18 weeks, 24 weeks

A questionnaire about goal of life, current crisis/goal, positivity, preparation and practice.

Change in level of PHQ-9 of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeks

9-question instrument given to caregivers in a primary care setting to screen for the presence and severity of depression.

Change in level of Crisis Overcoming Capability(SAT-SF) of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeks

A questionnaire about goal of life, current crisis/goal, positivity, preparation and practice of family caregivers.

Change in Advance Care Preference of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeks

Questions about family caregivers' preference on advance directive and treatment in case of terminal condition

Change in Quality Care QuestionnaireBaseline, 12 weeks, 3 months after death

The 4-factor, 32-item Quality Care Questionnaire-Palliative Care (QCQ-PC), which covers appropriate communication with health care professionals (ten items), discussing value of life and goals of care (nine items), support and counseling for needs of holistic care (seven items), and accessibility and sustainability of care (six items).

Change in Advance Care PreferenceBaseline, 12 weeks, 18 weeks, 24 weeks

Questions about advance directive and treatment preference in case of terminal condition

Changes of CQOLBaseline, 12 weeks, 18 weeks, 24 weeks

A questionnaire that measures quality of life and burden for family caregivers

Medical cost and utilization of CAM12 weeks, 24 weeks

Overall medical cost savings (cost effectiveness) and use of complementary and alternative medicine

1 year survival1 year

1 year survival

Change in level of Understanding the illness of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeks

2 questions to assess how family caregivers understand the prognosis of patients' illness

Trial Locations

Locations (10)

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Chonbuk National University Hospital

🇰🇷

Jeonju, Jeollabuk-do, Korea, Republic of

Gyeongsang National University Hospital

🇰🇷

Jinju-si, Gyeongsangnam-do, Korea, Republic of

Ulsan University Hospital

🇰🇷

Ulsan, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Chonnam National University Hwasun Hospital

🇰🇷

Hwasun, Jeollanam-do, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath